| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,999 |
13,462 |
$2.70M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,157 |
13,500 |
$2.68M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,332 |
6,314 |
$1.19M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,751 |
4,733 |
$885K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,638 |
1,579 |
$311K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,687 |
2,616 |
$225K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,040 |
1,038 |
$190K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,859 |
7,637 |
$111K |
| 99215 |
Prolong outpt/office vis |
525 |
515 |
$95K |
| 93975 |
|
611 |
603 |
$56K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,849 |
1,838 |
$53K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
976 |
954 |
$44K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
654 |
648 |
$40K |
| 80053 |
Comprehensive metabolic panel |
11,148 |
10,594 |
$32K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,633 |
8,332 |
$18K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,569 |
5,435 |
$15K |
| 99051 |
|
5,406 |
5,273 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,997 |
8,814 |
$12K |
| 93971 |
|
539 |
534 |
$12K |
| 70450 |
Computed tomography, head or brain; without contrast material |
967 |
960 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,079 |
2,048 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,528 |
1,510 |
$10K |
| 12001 |
|
66 |
66 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
2,661 |
2,617 |
$8K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
454 |
449 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,606 |
10,897 |
$8K |
| 99053 |
|
2,841 |
2,791 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
751 |
744 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
242 |
241 |
$7K |
| 80061 |
Lipid panel |
1,110 |
1,107 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,223 |
1,203 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
236 |
235 |
$6K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
112 |
112 |
$6K |
| 84439 |
|
767 |
758 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,234 |
1,219 |
$5K |
| 99205 |
Prolong outpt/office vis |
30 |
30 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$5K |
| 76830 |
Ultrasound, transvaginal |
363 |
359 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
3,739 |
3,576 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,986 |
3,762 |
$3K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
109 |
107 |
$3K |
| 76770 |
|
55 |
55 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
38 |
38 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,801 |
5,040 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,063 |
2,028 |
$2K |
| 83735 |
|
1,511 |
1,441 |
$1K |
| 82728 |
|
112 |
111 |
$1K |
| 81001 |
|
5,272 |
5,077 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
359 |
347 |
$1K |
| 76857 |
|
119 |
119 |
$1K |
| 73630 |
|
860 |
858 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
358 |
347 |
$1K |
| 86618 |
|
319 |
317 |
$938.55 |
| 36416 |
|
109 |
108 |
$928.87 |
| 86140 |
|
305 |
296 |
$784.27 |
| 76775 |
|
28 |
28 |
$709.22 |
| 81025 |
|
3,876 |
3,762 |
$699.03 |
| 76536 |
|
26 |
25 |
$696.91 |
| 90715 |
|
54 |
54 |
$619.28 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
17 |
17 |
$597.93 |
| 70486 |
|
12 |
12 |
$570.58 |
| 83690 |
|
2,639 |
2,574 |
$554.83 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,267 |
4,209 |
$502.93 |
| 83540 |
|
108 |
107 |
$461.68 |
| 81003 |
|
2,833 |
2,780 |
$455.64 |
| 73610 |
|
646 |
643 |
$450.38 |
| 85652 |
|
367 |
360 |
$429.98 |
| 73130 |
|
457 |
452 |
$393.82 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
84 |
78 |
$369.61 |
| 83550 |
|
80 |
79 |
$338.84 |
| 84702 |
|
402 |
376 |
$324.52 |
| 87468 |
|
112 |
110 |
$315.38 |
| 73030 |
|
88 |
88 |
$304.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
84 |
82 |
$283.51 |
| 87484 |
|
112 |
110 |
$276.72 |
| 82607 |
|
24 |
24 |
$268.25 |
| 87088 |
|
1,863 |
1,839 |
$265.24 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,365 |
2,309 |
$247.10 |
| 74018 |
|
41 |
41 |
$210.52 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
100 |
100 |
$196.44 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,281 |
3,188 |
$180.71 |
| 73564 |
|
52 |
52 |
$174.73 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
89 |
89 |
$174.03 |
| 84484 |
|
1,990 |
1,904 |
$163.48 |
| 86308 |
|
485 |
479 |
$113.13 |
| 85027 |
|
36 |
36 |
$108.80 |
| 85379 |
|
336 |
334 |
$101.37 |
| 73110 |
|
205 |
204 |
$97.50 |
| 87420 |
|
472 |
468 |
$94.32 |
| 87469 |
|
71 |
71 |
$81.96 |
| 73562 |
|
12 |
12 |
$54.09 |
| 87077 |
|
287 |
287 |
$48.97 |
| 72110 |
|
27 |
27 |
$48.18 |
| 85610 |
|
26 |
25 |
$39.34 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
256 |
253 |
$39.26 |
| 87070 |
|
352 |
350 |
$24.53 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,619 |
2,563 |
$19.97 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,796 |
1,751 |
$19.17 |
| 83605 |
|
99 |
94 |
$18.60 |
| 87186 |
|
142 |
142 |
$13.18 |
| 82947 |
|
53 |
52 |
$11.79 |
| 71045 |
Radiologic examination, chest; single view |
37 |
36 |
$10.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
364 |
354 |
$9.24 |
| 73140 |
|
25 |
25 |
$7.50 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
839 |
827 |
$5.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
563 |
561 |
$4.33 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
408 |
397 |
$2.00 |
| 87040 |
|
13 |
13 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
42 |
42 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
141 |
138 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
14 |
$0.00 |
| 82962 |
|
47 |
45 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
50 |
50 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
14 |
14 |
$0.00 |
| 99001 |
|
134 |
132 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
82 |
81 |
$0.00 |
| 93041 |
|
12 |
12 |
$0.00 |
| 87905 |
|
14 |
13 |
$0.00 |
| 87899 |
|
14 |
13 |
$0.00 |